An Examination of Fluoxetine for the Treatment of Selective Mutism Using a Nonconcurrent Multiple-Baseline Single-Case Design Across 5 Cases
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
This study examined the utility of fluoxetine in the treatment of 5 children, aged 5 to 14 years, diagnosed with selective mutism who also demonstrated symptoms of social anxiety. A nonconcurrent, randomized, multiple-baseline, single-case design with a single-blind placebo-controlled procedure was used. Parents and the study psychiatrist completed multiple methods of assessment including Direct Behavior Ratings and questionnaires. Treatment outcomes were evaluated by calculating effect sizes for each participant as an individual and for the participants as a group. Information regarding adverse effects with an emphasis on behavioral disinhibition and ratings of parental acceptance of the intervention was gathered. All 5 children experienced improvement in social anxiety, responsive speech, and spontaneous speech with medium to large effect sizes; however, children still met criteria for selective mutism at the end of the study. Adverse events were minimal, with only 2 children experiencing brief occurrences of minor behavioral disinhibition. Parents found the treatment highly acceptable. © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Use of Single-Subject Research to Identify Evidence-Based Practice in Special Education
Horner, R. H., Carr, E. G., Halle, J., McGee, G., Odom, S., & Wolery, M. (2005) · Exceptional Children · doi:10.1177/001440290507100203 · Cited by 3,368
Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442
ACCEPTABILITY OF ALTERNATIVE TREATMENTS FOR DEVIANT CHILD BEHAVIOR
Kazdin, A. E. (1980) · Journal of Applied Behavior Analysis · doi:10.1901/jaba.1980.13-259 · Cited by 692
Watson, P. J., & Workman, E. A. (1981) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(81)90055-0 · Cited by 458
Fluoxetine for the Treatment of Childhood Anxiety Disorders
BIRMAHER, B., AXELSON, D. A., MONK, K., KALAS, C., CLARK, D. B., EHMANN, M., BRIDGE, J., HEO, J., & BRENT, D. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000037049.04952.9f · Cited by 385
The Case Against Statistical Significance Testing, Revisited
Carver, R. P. (1993) · The Journal of Experimental Education · doi:10.1080/00220973.1993.10806591 · Cited by 319
Prevalence and Description of Selective Mutism in a School-Based Sample
BERGMAN, R. L., PIACENTINI, J., & MCCRACKEN, J. T. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200208000-00012 · Cited by 291
Evaluation of the Clinical Global Impression Scale among individuals with social anxiety disorder
ZAIDER, T. I., HEIMBERG, R. G., FRESCO, D. M., SCHNEIER, F. R., & LIEBOWITZ, M. R. (2003) · Psychological Medicine · doi:10.1017/s0033291703007414 · Cited by 286
Treatment of Elective Mutism with Fluoxetine: A Double-Blind, Placebo-Controlled Study
BLACK, B., & UHDE, T. W. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199409000-00010 · Cited by 278
Fluoxetine Treatment of Children with Selective Mutism: An Open Trial
DUMMIT, E. S., KLEIN, R. G., ASCHE, B., MARTIN, J., & TANCER, N. K. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199605000-00016 · Cited by 188
Research works printed but not linked: 1
- 1985, Ratings scales and assessment instruments for use in pediatric psychopharmacology research, Psychopharmacol Bull, 21, 839
Cited by
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086295 · Cited by 158
“Medication Small DBPC studies which do not fulfil the criteria of this guideline because of small sample sizes showed some effect of fluoxetine and sertraline (Barterian et al. 2018; Black and Uhde 1994; Carlson et al. 1999).”
BackgroundDiagnosing selective mutism: a critical review of measures for clinical practice and research
Pereira, C. R., Ensink, J. B. M., Güldner, M. G., Lindauer, R., de Jonge, M. V., & Utens, E. M. W. J. (2021) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01907-2 · Cited by 36
“Finally, other widely used general measures to assess global functioning, impairment and improvement (GAF; [80], CGAS; [81], CGI-S/I; [83]) have been used in several studies as severity and treatment outcome measures [19, 21, 29, 35, 36, 44, 55, 60, 70, 74, 82].”
BackgroundMethodInfluentialBorst, M., Moeyaert, M., & van Rood, Y. (2024) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2024.2314883 · Cited by 12
“To control for placebo e ff ects, a placebo phase can be added directly after the baseline phase, see Barterian et al. (2018) for an example.”
Ruiz, E., Beatty, A., & Weyandt, L. L. (2023) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0090 · Cited by 6
Practical Tips for Paediatricians: Helping kids find their voices in selective mutism
Wang, R., & Monga, S. (2023) · Paediatrics & Child Health · doi:10.1093/pch/pxad043 · Cited by 2
Metadata
- Authors
- BARTERIAN, J. A., SANCHEZ, J. M., MAGEN, J., SIROKY, A. K., MASH, B. L., & CARLSON, J. S.
- Affiliations
- The Ohio State University (US)
- Venue
- Journal of Psychiatric Practice
- Published
- 2018-01
- Volume
- 24
- Issue
- 1
- Pages
- 2-14
- ISSN
- 1527-4160 (ISSN-L)
- 1538-1145
- OpenAlex
- W2914640387
- Cited by
- 11
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2019: 1
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychiatric Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Clinical Psychology › Stuttering Research and Treatment
- Keywords
- fluoxetine, selective mutism, social anxiety, children, selective serotonin reuptake inhibitors, speech development, behavioral disinhibition, parental acceptance, treatment acceptability, adverse effects
- MeSH terms
- Phobia, Social, Adolescent, Child, Child, Preschool, Female, Fluoxetine, Humans, Male, Mutism, Single-Blind Method, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Examination of Fluoxetine for the Treatment of Selective Mutism Using a Nonconcurrent Multiple-Baseline Single-Case Design Across 5 Cases. https://app.cochat.ai/papers/10.1097/pra.0000000000000284
- The paper
- BARTERIAN, J. A., SANCHEZ, J. M., MAGEN, J., SIROKY, A. K., MASH, B. L., & CARLSON, J. S. (2018). An Examination of Fluoxetine for the Treatment of Selective Mutism Using a Nonconcurrent Multiple-Baseline Single-Case Design Across 5 Cases. Journal of Psychiatric Practice. https://doi.org/10.1097/pra.0000000000000284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.